Data2Life

Company Overview

Snapshot

Founded in February 2014 by Itzik Lichtenfeld and Limor BH Epstein, Data2Life operated with 1–10 employees. The company raised $4.3 million across one funding round. In January 2020, Data2Life ceased operations.

Business overview

Data2Life developed solutions for patient-centered real-world evidence (RWE) analytics, focusing on distilling and analyzing patient-generated data and integrating it with traditional datasets. The company built a B2B drug intelligence platform designed to deliver holistic RWE, precise and personalized patient profiles, and predictive trends for therapeutic journeys. Data2Life utilized artificial intelligence analytics, including proprietary deep-learning algorithms, for applications in healthcare, cannabis, and drug development, operating within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Data2Life's primary focus?

Data2Life focuses on providing multidimensional health intelligence through solutions that offer easy access to patient-centered real-world evidence (RWE) analytics.

When was Data2Life founded?

Data2Life was founded in February 2014.

What was Data2Life's operational status?

Data2Life ceased to operate in January 2020.

What technologies did Data2Life utilize?

Data2Life invested heavily in artificial intelligence analytics, focusing on proprietary deep-learning algorithms for healthcare, cannabis, and drug development.

What was the total capital raised by Data2Life?

Data2Life raised a total of $4.3 million across one funding round.